Pulsatile drug delivery system of ibuprofen and famotidine
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-002
- By: AGRAWAL, Surendra (SPPSPTM, NMIMS, Quality Assurance, Mumbai, India)
- Co-author(s): Gaud, Ram (SPPSPTM, NMIMS, Mumbai, India)
Verma, Saroj (SPPSPTM, NMIMS, Mumbai, India)
Purpose: In April 2011 US-FDA has approved Duexis which is a formulation of Ibuprofen, combined with Famotidine, in a single pill. The developed pill was unable to meet the chronotherapeutic goals, which have recently been highlighted in connection with chronic diseases with typical night or early morning recurrence of symptoms.
Preparation and.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.